Management of Anthracycline-Induced Cardiac Toxicity: Emphasis on Early Recognition and Management in the Cancer Survivor
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Explain the possible benefits of screening for and early recognition of heart failure in survivors with a history of anthracycline exposure
Crystal S. Denlinger, MD
Fox Chase Cancer Center
- 1.00 Participation
- 0.92 Nurse
- 1.00 Pharmacist
- 1.00 Physician